We are delighted to welcome Dr. Uwe Gottschalk to Biovian’s Board of Directors. “At Keensight, we are very pleased to welcome Uwe to the Board of Biovian” said Dr. Pierre Remy, Chairman of the Board. …
Biovian is delighted to announce that Allison Allen has been appointed the first US-based Head of Global Business Development. “We are very pleased that Allison Allen will assume the role Business Development Manager at Biovian” …
Biovian is looking forward to participating in the BIO International Convention on June 13th-16th in San Diego. #BIO2022 is back in person. Biovian representatives, CBO Magnus Gustafsson and Head of Business Development Eero Mustalahti are …
Viral contaminations are rare events in biopharmaceutical manufacturing, but regulatory agencies expect all biologics to undergo viral clearance testing to mitigate the risk of contamination [1, 2]. Therapies based on viral vectors have a small …
Biovian, a Finnish Contract Development and Manufacturing Organization, CDMO, has year after year received a high net promoter score, NPS. NPS measures customer satisfaction and loyalty by asking clients how likely they are to recommend …
What does a project manager do and what is needed to be successful in such a position? The job title has a broad meaning and job descriptions for project managers vary greatly. Even within the …
Biovian’s client satisfaction survey was conducted in November using Net Promoter Score (NPS) survey. The score of 67 puts Biovian into the category “Excellent” based on the creators of NPS, Bain & Co. Flexibility, good …
New Horizons 2021 event took place on December 9th in Stockholm. Dr. Magnus Gustafsson from Biovian gave a talk about “Gene therapy today and tomorrow.” New Horizons is an international educational forum that focuses on …
Biovian and Lokon Pharma are featured in Biopharma Dealmakers September issue. The article “Manufacturing the next generation of cancer immunotherapeutics”, describes the history and currents state of Lokon Pharma’s proprietary LOAd technology. This immunostimulatory gene …
Outsourcing as a business model within the Life Science-industry is growing year by year. Choosing the right contract development and manufacturing organization (CDMO) has become an important factor for the success of drug product development. …
